Skip to content
healthcare.dev
Get a free key

Ezetimibe

NDC 76333-170, Ezetimibe, tablet, from Orient Pharma Co., Ltd..

Product NDC
76333-170
Status
Listed
Labeler
Orient Pharma Co., Ltd.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215693
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76333-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EZETIMIBE10 mg/1

Pharmacologic classes

Decreased Cholesterol Absorption [PE]; Dietary Cholesterol Absorption Inhibitor [EPC]

Package NDCNDC-11Package
76333-170-12763330170121000 TABLET in 1 BOTTLE (76333-170-12)
76333-170-1376333017013500 TABLET in 1 BOTTLE (76333-170-13)
76333-170-147633301701490 TABLET in 1 BOTTLE (76333-170-14)
76333-170-157633301701530 TABLET in 1 BOTTLE (76333-170-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b6e77d9b-a553-63e0-e053-2a95a90a18fe

Use it

Look up 76333-170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76333-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76333-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.